The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Elranatamab in combination with daratumumab and lenalidomide (EDR) in patients with newly diagnosed multiple myeloma (NDMM) not eligible for transplant: Initial results from MagnetisMM-6 part 1.
 
Hang Quach
Consulting or Advisory Role - Antengene (Inst); Bristol-Myers Squibb/Celgene; GlaxoSmithKline (Inst); Janssen-Cilag; Karyopharm Therapeutics (Inst); Pfizer; Roche; Sanofi (Inst)
Research Funding - Amgen; Bristol-Myers Squibb/Celgene; Celgene; GlaxoSmithKline; Karyopharm Therapeutics; Sanofi
 
Ludek Pour
No Relationships to Disclose
 
Sebastian Grosicki
No Relationships to Disclose
 
Hanlon Sia
No Relationships to Disclose
 
Jiri Minarik
No Relationships to Disclose
 
Ja Min Byun
No Relationships to Disclose
 
Cyrille Touzeau
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb/Celgene; Janssen; Pfizer; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb/Celgene; Janssen; Pfizer; Takeda
Research Funding - Sanofi (Inst)
Travel, Accommodations, Expenses - Johnson & Johnson/Janssen; Pfizer; Sanofi
 
Carmine Liberatore
No Relationships to Disclose
 
Sharon Sullivan
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Eric Leip
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Eeman Shaikh
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer (I)
 
Andrea Viqueira
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Meletios Dimopoulos
Honoraria - Amgen; AstraZeneca; Beigene; Bristol-Myers Squibb; GlaxoSmithKline; Janssen-Cilag; Menarini; Regeneron; Sanofi; Swixx BioPharma; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Beigene; Bristol-Myers Squibb; GlaxoSmithKline; Janssen-Cilag; Menarini; Regeneron; Sanofi; Swixx BioPharma; Takeda
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb/Celgene; Janssen; Takeda